The Synthetic Peptide Trp-Lys-Tyr-Met-Val-Met-NH2 Specifically Activates Neutrophils through FPRL1/Lipoxin A4 Receptors and Is an Agonist for the Orphan Monocyte-expressed Chemoattractant Receptor FPRL2Thierry Christophe, Cláes Dahlgren, Anna Karlsson et al.|Journal of Biological Chemistry|2001Cited by 205
The synthetic chemoattractant Trp-Lys-Tyr-Met-Val-DMet activates neutrophils preferentially through the lipoxin A4 receptorCláes Dahlgren, Anna Karlsson, Thierry Christophe et al.|Blood|2000Cited by 124
Proinflammatory Activity of a Cecropin-Like Antibacterial Peptide from<i>Helicobacter pylori</i>Johan Bylund, Cláes Dahlgren, Thierry Christophe et al.|Antimicrobial Agents and Chemotherapy|2001Cited by 66
Phagocyte Activation by Trp–Lys–Tyr–Met–Val–Met, Acting through FPRL1/LXA<sub>4</sub>R, is not Affected by Lipoxin A<sub>4</sub>Thierry Christophe, Cláes Dahlgren, Anna Karlsson et al.|Scandinavian Journal of Immunology|2002Cited by 51
Identification of GLPG/ABBV-2737, a Novel Class of Corrector, Which Exerts Functional Synergy With Other CFTR ModulatorsGert De Wilde, Katja Conrath, Steven Van der Plas et al.|Frontiers in Pharmacology|2019Cited by 40